Posted on 6/21/16
Spark Therapeutics Announces Closing of Public Offering
PHILADELPHIA, June 20, 2016 (GLOBE NEWSWIRE) -- Spark Therapeutics, Inc.(NASDAQ:ONCE) announced today the closing of its previously announced underwritten public offering of common stock pursuant to . . .
Posted on 6/21/16
Medgenics Announces Public Offering of Common Stock
Medgenics, Inc. (NYSE: MDGN), a clinical-stage biopharmaceutical company, today announced its intention to offer and sell shares of its common stock in an underwritten public offering . . .
Posted on 6/20/16
Better Buy: Ziopharm Oncology, Inc. vs. Celgene
T-CELLS ATTACKING CANCER CELL. IMAGE SOURCE: GETTY IMAGES.If you haven't been watching the biotech space over the past year, there are three things you need to . . .
Posted on 6/20/16
Better Buy: AbbVie Inc. vs. Johnson & Johnson
IMAGE SOURCE: JOHNSON & JOHNSON.Biopharmaceutical pure play AbbVie (NYSE:ABBV) has been on a spending spree in an attempt to offset impending competition for a huge chunk . . .
Posted on 6/20/16
Digging Below the Surface: Here's What Celgene's New Stock Buyback Really Implies
IMAGE SOURCE: GETTY IMAGES.Business is booming for big biotech, which is evident when you take a closer look at Celgene(NASDAQ:CELG).Celgene's bread-and-butter product is Revlimid, the leading . . .
Posted on 6/17/16
InstaMed Releases Sixth Annual Trends in Healthcare Payments Report
InstaMed, healthcare’s most trusted payments network, has released the 2015 Trends in Healthcare Payments Annual Report. This is the sixth annual report from InstaMed and features . . .
Posted on 6/17/16
Merck & Co., Inc. Wins This Round of the Immunotherapy Lung-Cancer Battle
IMAGE SOURCE: MERCK.Merck (NYSE:MRK) looks like it will win the race to have the first immunotherapy drug to gain Food and Drug Administration approval to treat . . .
Posted on 6/17/16
AAC Holdings Commences Development of 150-Bed Treatment Center in New Jersey
BRENTWOOD, Tenn. & RINGWOOD, N.J.--(BUSINESS WIRE)--AAC Holdings, Inc. (NYSE: AAC) announced that it has commenced development of a 150-bed residential treatment center at the site of . . .
Posted on 6/17/16
Amneal Pharmaceuticals Honored with Best Overall Generics Manufacturer Award by Healthcare Distribution Alliance
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals today announced the company was recently honored with the Distribution Industry Award for Notable Achievements in Healthcare (DIANA) for Generic Pharmaceutical Product . . .
Posted on 6/16/16
Cyclacel Regains Compliance With Nasdaq Continued Listing Requirements
BERKELEY HEIGHTS, N.J., June 16, 2016 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP), a biopharmaceutical company developing oral therapies that target the various phases of . . .
Posted on 6/16/16
Better Buy: Johnson & Johnson vs. Eli Lilly
IMAGE SOURCE: GETTY IMAGES.Pharmaceutical stocks have been hammered over the past year, leaving potential buyers with a plethora of potential bargains. At Johnson & Johnson (NYSE:JNJ), . . .
Posted on 6/16/16
Champions Oncology Closes Stock Offering
Champions Oncology, Inc. (NASDAQ: CSBR) a company engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology . . .
Posted on 6/16/16
Celgene Announces Additional $3 Billion Share Repurchase Authorization
SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ:CELG) today announced that during its June meeting the Company's Board of Directors authorized the repurchase of up to an additional $3.0 . . .
Posted on 6/15/16
3 Biotech Stocks to Buy If the Market Crashes
Jun 14, 2016 at 4:20PM IMAGE SOURCE: GETTY IMAGES.Celgene Corp. (NASDAQ:CELG), Regeneron Pharmaceuticals (NASDAQ:REGN), andGilead Sciences (NASDAQ:GILD) aren't immune to broader market pops and drops, but . . .
Posted on 6/15/16
Should Pfizer Buy This Beaten-Down Immuno-Oncology Company?
Bristol-Myers Squibb (NYSE: BMY) and Merck's(NYSE:MRK)game-changing(NYSE:MRK)immuno-oncology drugs, Opdivo and Keytruda, respectively, have triggered an avalanche of research into so-called "checkpoint inhibitors" due to their stunning commercial . . .
Posted on 6/15/16
Spark Therapeutics Announces Pricing of Public Offering
PHILADELPHIA, June 14, 2016 (GLOBE NEWSWIRE) -- Spark Therapeutics, Inc.(NASDAQ:ONCE) announced today the pricing of an underwritten public offering of 3,500,000 shares of its common stock . . .
Posted on 6/14/16
RCCA and Osler Health Join Forces to Provide Cancer Care using Collaborative Physician Teams
Cancer patients have good reason to be more optimistic about the quality and effectiveness of their care in the near future. Regional Cancer Care Associates LLC, . . .
Posted on 6/14/16
Spark Therapeutics Announces Launch of Public Offering
PHILADELPHIA, June 13, 2016 (GLOBE NEWSWIRE) -- Spark Therapeutics, Inc.(NASDAQ:ONCE) announced today that it has commenced an underwritten public offering of 3,500,000 shares of its common . . .
Posted on 6/14/16
United Health Foundation Partnership with New Jersey Hospital Association
PRINCETON, N.J.--(BUSINESS WIRE)--The New Jersey Hospital Association (NJHA) and United Health Foundation brought together health professionals and military leaders today to raise awareness about the complexities . . .
Posted on 6/13/16
Celsion Corp. Announces $6 Million Offering
Celsion Corporation (NASDAQ:CLSN) today announced that it has entered into a definitive agreement with a single healthcare dedicated institutional investor to purchase an aggregate of approximately $6 . . .
Posted on 6/13/16
BioScrip Acquires Home Solutions
BioScrip, Inc. (NASDAQ:BIOS), a leading national provider of infusion and home care management solutions, today announced that it has entered into an agreement
Posted on 6/13/16
Johnson & Johnson: Can Anything Slow It Down?
Johnson & Johnson (NYSE:JNJ) is at all-time highs, once again. And given the strong year-to-date performance, I want to examine this consumer behemoth more closely to . . .
Posted on 6/10/16
Better Buy: GlaxoSmithKline vs. Pfizer
Investing in the world of healthcare can be downright scary. Just look at what happened nearly overnight to shareholders of Celldex recently. But when you consider . . .
Posted on 6/10/16
Why PTC Therapeutics Jumped 10% In May
IMAGE SOURCE: PTC THERAPEUTICS.What: After the company reported first quarter financials and updated investors on the progress it's making with Translarna, a therapy for Duchenne muscular . . .
Posted on 6/10/16
Champions Oncology Prices Stock Offering
Champions Oncology, Inc. (NASDAQ: CSBR), a company engaged in the development and sale of advanced technology solutions and products to personalize the development and use of . . .
Philadelphia
